Morgan Stanley and Raymond James Financial raised their price objectives for Elevance Health, Inc. on September 15, 2026.

The entities involved

• Morgan Stanley →

  U.S. investment bank

  • Keefe, Bruyette & Woods boosted its price objective on Assurant while Morgan Stanley reduced its price target on the shares.16:57
  • Multiple financial firms issued rating and price target updates on November 4, 2026.14:11
• Elevance Health, Inc. →

  American healthcare company

  • Morgan Stanley issued a research note on Elevance Health shares as the company filed its 13F reports with the SEC.Mon 14:27
• Raymond James Financial →

  American Investment Bank and Financial Services Firm

  • CIBC, Scotiabank, and Raymond James Financial issued rating updates, including upgrades and neutral ratings, on Interfor shares.13:10
  • Horace Mann Educators Corporation filed a Form 13F with the SEC and received analyst reports.12:31

Related events

• Multiple financial firms, including Jefferies, Bank of America, and Raymond James, issued price objective and rating updates on October 23, 2026.Oct 24
• Morgan Stanley raised its price objective for Disc Medicine, Inc. on June 30, 2026.Jul 1
• Morgan Stanley raised its price objective to $77.00 and maintained an underperform rating for LyondellBasell Industries.Jun 7
• Raymond James Financial, Keefe, Bruyette & Woods, and Stephens issued rating upgrades and assumed coverage for EFSC.Oct 21
• Analyst firms provided ratings and price targets for Merit Medical Systems on August 28, 2026, involving Raymond James Financial and Bank of America Corp.Aug 29